Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.56 |
| ▸ | MAOA | P21397 | 2/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | CTSV | O60911 | 3/20 | 0.52 |
| ▸ | CTSL | P07711 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | NSD2 | O96028 | 1/20 | 0.51 |
| ▸ | AS3MT | Q9HBK9 | 1/20 | 0.51 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.51 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.49 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29652545 | 1.00 | TRPM8 (0.56) | TRPM8MAOAMAOBKDM4EMAPT | |
| SCHEMBL4151637 | 0.96 | TRPM8 (0.57) | TRPM8MAOAMAOBKDM4EMAPT | |
| SCHEMBL4158966 | 0.95 | TRPM8 (0.52) | TRPM8MAOAMAOBKDM4EMAPT | |
| SCHEMBL4156633 | 0.95 | TRPM8 (0.54) | TRPM8MAOAMAOBKDM4EMAPT | |
| SCHEMBL4155146 | 0.94 | TRPM8 (0.53) | TRPM8MAOAMAOBKDM4EMAPT | |
| SCHEMBL4144271 | 0.93 | TRPM8 (0.52) | TRPM8MAOAMAOBKDM4EMAPT | |
| SCHEMBL8610000 | 0.93 | CTSV (0.53) | TRPM8MAOAMAOBKDM4EMAPT | |
| SCHEMBL19949651 | 0.93 | TRPM8 (0.52) | TRPM8MAOAMAOBKDM4EMAPT | |
| SCHEMBL12585390 | 0.92 | TRPM8 (0.48) | TRPM8MAOAMAOBKDM4EMAPT | |
| SCHEMBL4156110 | 0.91 | CTSV (0.52) | TRPM8MAOAMAOBMAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 210 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110627704-B | Preparation method of bazedoxifene | 艾瑞吉瑞股份公司 | 2024-02-23 | — | — | CN | claimed |
| CN-117538450-A | Detection method of bazedoxifene acetate intermediate | 江苏正济药业股份有限公司 | 2024-02-09 | — | — | CN | claimed |
| CN-107793344-B | Industrial production method of bazedoxifene acetate | 扬子江药业集团有限公司 | 2021-01-12 | — | — | CN | claimed |
| US-10844047-B2 | Process for the preparation of bazedoxifene | ERREGIERRE S.P.A. (IT) | 2020-11-24 | — | — | US | claimed |
| CN-106810487-B | Efficient preparation method of bazedoxifene | 四川科伦药物研究院有限公司 | 2020-03-17 | — | — | CN | claimed |
| CN-110627704-A | Preparation method of bazedoxifene | 艾瑞吉瑞股份公司 | 2019-12-31 | — | — | CN | claimed |
| CN-107793344-A | A kind of industrialized preparing process of bazedoxifene acetate | 扬子江药业集团有限公司 | 2018-03-13 | — | — | CN | claimed |
| CN-106810487-A | A kind of high efficiency preparation method of Bazedoxifene | 四川科伦药物研究院有限公司 | 2017-06-09 | — | — | CN | claimed |
| CN-104311468-A | Bazedoxifene impurity synthesis method | AVENTIS PHARMA HAINAN CO LTD | 2015-01-28 | — | — | CN | claimed |
| US-8569483-B2 | Process for the preparation of bazedoxifene acetate and intermediates thereof | Divi's Laboratories, Ltd. (IN) | 2013-10-29 | — | — | US | claimed |
| US-20120330008-A1 | NOVEL PROCESS FOR THE PREPARATION OF BAZEDOXIFENE ACETATE AND INTERMEDIATES THEREOF | DIVI'S LABORATORIES LIMITED (IN) | 2012-12-27 | — | — | US | claimed |
| EP-2118058-B9 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA KS (CZ) | 2012-03-28 | — | — | EP | claimed |
| EP-2426105-A1 | Process for the preparation of 5-benzyloxy-2-(4-benzyloxyphenyl)-3-methyl-1h-indole | Divi's Laboratories Limited (IN) | 2012-03-07 | — | — | EP | claimed |
| US-7968732-B1 | Process for the preparation of 5-benzyloxy-2-(4-benzyloxyphenyl)-3-methyl-1H-indole | Divi's Laboratories, Ltd. (IN) | 2011-06-28 | — | — | US | claimed |
| EP-2118058-B1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA KS (CZ) | 2011-06-08 | — | — | EP | claimed |
| US-20100087661-A1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA K.S. (CZ) | 2010-04-08 | — | — | US | claimed |
| EP-2118058-A1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | Zentiva, k.s. (CZ) | 2009-11-18 | — | — | EP | claimed |
| WO-2008098527-A1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA A.S. (CZ) | 2008-08-21 | — | — | WO | claimed |
| EP-1025077-B1 | NOVEL ARYLOXY-ALKYL-DIALKYLAMINES | WYETH CORP (US) | 2007-02-28 | — | — | EP | claimed |
| CN-110627704-B | Preparation method of bazedoxifene | 艾瑞吉瑞股份公司 | 2024-02-23 | — | — | CN | disclosed |
| CN-110627704-B | Preparation method of bazedoxifene | 艾瑞吉瑞股份公司 | 2024-02-23 | — | — | CN | disclosed |
| CN-117538450-A | Detection method of bazedoxifene acetate intermediate | 江苏正济药业股份有限公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-117538450-A | Detection method of bazedoxifene acetate intermediate | 江苏正济药业股份有限公司 | 2024-02-09 | — | — | CN | disclosed |
| EP-3512842-B1 | INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | ARVINAS INC (US) | 2024-01-17 | — | — | EP | disclosed |
| EP-3512842-B1 | INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | ARVINAS INC (US) | 2024-01-17 | — | — | EP | disclosed |
| US-11667621-B2 | Antiestrogen compounds | STEVENS INSTITUTE OF TECHNOLOGY (US) | 2023-06-06 | — | — | US | disclosed |
| US-20230158152-A1 | PROTEOLYSIS REGULATOR AND METHOD FOR USING SAME | MEDSHINE DISCOVERY INC. (CN) | 2023-05-25 | — | — | US | disclosed |
| WO-2023023531-A1 | ESTROGEN RECEPTOR DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | BIOTHERYX, INC. (US) | 2023-02-23 | — | — | WO | disclosed |
| WO-2023023531-A1 | ESTROGEN RECEPTOR DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | BIOTHERYX, INC. (US) | 2023-02-23 | — | — | WO | disclosed |
| US-11584743-B2 | Indole derivatives as estrogen receptor degraders | ARVINAS OPERATIONS, INC. (US) | 2023-02-21 | — | — | US | disclosed |
| US-11584743-B2 | Indole derivatives as estrogen receptor degraders | ARVINAS OPERATIONS, INC. (US) | 2023-02-21 | — | — | US | disclosed |
| EP-4122925-A1 | PROTEOLYSIS REGULATOR AND METHOD FOR USING SAME | Medshine Discovery Inc. (CN) | 2023-01-25 | — | — | EP | disclosed |
| CN-115594625-A | Method for preparing bazedoxifene | 济南明微医药科技有限公司（CN） | 2023-01-13 | — | — | CN | disclosed |
| CN-111060619-B | Method for detecting bazedoxifene acetate impurity | 北京鑫开元医药科技有限公司 | 2022-11-18 | — | — | CN | disclosed |
| CN-112110845-B | Synthesis method of bazedoxifene and analogues thereof | 中国科学院福建物质结构研究所 | 2022-06-10 | — | — | CN | disclosed |
| CN-113816892-A | Synthesis method of bazedoxifene acetate | 安徽鼎旺医药有限公司 | 2021-12-21 | — | — | CN | disclosed |
| US-20210130320-A1 | ANTIESTROGEN COMPOUNDS | STEVENS INSTITUTE OF TECHNOLOGY (US) | 2021-05-06 | — | — | US | disclosed |
| US-20210040081-A1 | INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | Arvinas, Inc. | 2021-02-11 | — | — | US | disclosed |
| US-20210040081-A1 | INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | Arvinas, Inc. | 2021-02-11 | — | — | US | disclosed |
| CN-107793344-B | Industrial production method of bazedoxifene acetate | 扬子江药业集团有限公司 | 2021-01-12 | — | — | CN | disclosed |
| CN-107793344-B | Industrial production method of bazedoxifene acetate | 扬子江药业集团有限公司 | 2021-01-12 | — | — | CN | disclosed |
| CN-112110845-A | Synthesis method of bazedoxifene and analogues thereof | 中国科学院福建物质结构研究所 | 2020-12-22 | — | — | CN | disclosed |
| US-10865202-B2 | Indole derivatives as estrogen receptor degraders | ARVINAS OPERATIONS, INC. (US) | 2020-12-15 | — | — | US | disclosed |
| US-10865202-B2 | Indole derivatives as estrogen receptor degraders | ARVINAS OPERATIONS, INC. (US) | 2020-12-15 | — | — | US | disclosed |
| US-10844047-B2 | Process for the preparation of bazedoxifene | ERREGIERRE S.P.A. (IT) | 2020-11-24 | — | — | US | disclosed |
| US-10844047-B2 | Process for the preparation of bazedoxifene | ERREGIERRE S.P.A. (IT) | 2020-11-24 | — | — | US | disclosed |
| US-10844047-B2 | Process for the preparation of bazedoxifene | ERREGIERRE S.P.A. (IT) | 2020-11-24 | — | — | US | disclosed |
| CN-104569202-B | Method for separating and measuring bazedoxifene acetate and related substances thereof | 万特制药(海南)有限公司 | 2020-07-07 | — | — | CN | disclosed |
| CN-111060619-A | Method for detecting bazedoxifene acetate impurity | 北京鑫开元医药科技有限公司 | 2020-04-24 | — | — | CN | disclosed |
| CN-106810487-B | Efficient preparation method of bazedoxifene | 四川科伦药物研究院有限公司 | 2020-03-17 | — | — | CN | disclosed |
| CN-110627704-A | Preparation method of bazedoxifene | 艾瑞吉瑞股份公司 | 2019-12-31 | — | — | CN | disclosed |
| CN-110627704-A | Preparation method of bazedoxifene | 艾瑞吉瑞股份公司 | 2019-12-31 | — | — | CN | disclosed |
| US-20190233408-A1 | INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | Arvinas, Inc. | 2019-08-01 | — | — | US | disclosed |
| US-20190233408-A1 | INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | Arvinas, Inc. | 2019-08-01 | — | — | US | disclosed |
| EP-3512842-A1 | INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | Arvinas, Inc. (US) | 2019-07-24 | — | — | EP | disclosed |
| EP-2791133-B1 | FLUORINATED ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | SERAGON PHARMACEUTICALS INC (US) | 2019-04-17 | — | — | EP | disclosed |
| CN-105859606-B | Indole derivatives and its preparation method and application containing piperazinyl | 沈阳药科大学 | 2019-01-29 | — | — | CN | disclosed |
| CN-105732465-B | Phenyl-indoles compound and its preparation method and application | 沈阳药科大学 | 2019-01-29 | — | — | CN | disclosed |
| WO-2018053354-A1 | INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | Arvinas, Inc. (US) | 2018-03-22 | — | — | WO | disclosed |
| WO-2018053354-A1 | INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | Arvinas, Inc. (US) | 2018-03-22 | — | — | WO | disclosed |
| US-20180072711-A1 | INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | ARVINAS OPERATIONS, INC. | 2018-03-15 | — | — | US | disclosed |
| US-20180072711-A1 | INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | ARVINAS OPERATIONS, INC. | 2018-03-15 | — | — | US | disclosed |
| CN-107793344-A | A kind of industrialized preparing process of bazedoxifene acetate | 扬子江药业集团有限公司 | 2018-03-13 | — | — | CN | disclosed |
| CN-106810487-A | A kind of high efficiency preparation method of Bazedoxifene | 四川科伦药物研究院有限公司 | 2017-06-09 | — | — | CN | disclosed |
| CN-105859606-A | Piperazinyl-containing indole derivatives, and preparation method and application thereof | 沈阳药科大学 | 2016-08-17 | — | — | CN | disclosed |
| CN-105801564-A | Piperazinone compounds and application thereof | 沈阳药科大学 | 2016-07-27 | — | — | CN | disclosed |
| CN-105732465-A | Phenylindole compound and preparation method and application thereof | 沈阳药科大学 | 2016-07-06 | — | — | CN | disclosed |
| CN-104098499-B | The preparation method of 5-benzyloxy-2-(4-benzyloxy phenyl)-3-Methyl-1H-indole | SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) | 2016-05-04 | — | — | CN | disclosed |
| CN-104098499-B | The preparation method of 5-benzyloxy-2-(4-benzyloxy phenyl)-3-Methyl-1H-indole | SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) | 2016-05-04 | — | — | CN | disclosed |
| CN-104098499-B | The preparation method of 5-benzyloxy-2-(4-benzyloxy phenyl)-3-Methyl-1H-indole | SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY (CN) | 2016-05-04 | — | — | CN | disclosed |
| US-9193714-B2 | Fluorinated estrogen receptor modulators and uses thereof | SERAGON PHARMACEUTICALS, INC. (US) | 2015-11-24 | — | — | US | disclosed |
| CN-104311468-A | Bazedoxifene impurity synthesis method | AVENTIS PHARMA HAINAN CO LTD | 2015-01-28 | — | — | CN | disclosed |
| CN-104311468-A | Bazedoxifene impurity synthesis method | AVENTIS PHARMA HAINAN CO LTD | 2015-01-28 | — | — | CN | disclosed |
| US-20150005286-A1 | FLUORINATED ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | SERAGON PHARMACEUTICALS, INC. | 2015-01-01 | — | — | US | disclosed |
| CN-102690225-B | New synthetic method of bazedoxifene | NANJING ACESYS PHARMATECH CO LTD | 2014-12-24 | — | — | CN | disclosed |
| US-8889896-B2 | Process for the preparation of bazedoxifene acetate and intermediates thereof | Divi's Laboratories, Ltd. (IN) | 2014-11-18 | — | — | US | disclosed |
| US-20140329784-A1 | 2-PHENYL-1-[4-(2-AMINOETHOXY)-BENZYL]-INDOLE AND ESTROGEN FORMULATIONS | WYETH LLC (US) | 2014-11-06 | — | — | US | disclosed |
| EP-2791133-A1 | FLUORINATED ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | Seragon Pharmaceuticals, Inc. (US) | 2014-10-22 | — | — | EP | disclosed |
| CN-104114551-A | Fluorinated estrogen receptor modulators and uses thereof | ARAGON PHARMACEUTICALS INC | 2014-10-22 | — | — | CN | disclosed |
| CN-104098499-A | Preparation method for 5-benzyloxy-2-(4-benzyloxyphenyl)-3-methyl-1H-indole | SHANGHAI INST PHARM INDUSTRY | 2014-10-15 | — | — | CN | disclosed |
| CN-104098499-A | Preparation method for 5-benzyloxy-2-(4-benzyloxyphenyl)-3-methyl-1H-indole | SHANGHAI INST PHARM INDUSTRY | 2014-10-15 | — | — | CN | disclosed |
| CN-104098499-A | Preparation method for 5-benzyloxy-2-(4-benzyloxyphenyl)-3-methyl-1H-indole | SHANGHAI INST PHARM INDUSTRY | 2014-10-15 | — | — | CN | disclosed |
| CN-104013630-A | Compound bazedoxifene acetate estrogen composition | HEFEI JIUYAN MEDICINE TECHNOLOGY DEV CO LTD | 2014-09-03 | — | — | CN | disclosed |
| US-8815934-B2 | 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations | WYETH LLC (US) | 2014-08-26 | — | — | US | disclosed |
| US-20130289296-A1 | NOVEL PROCESS FOR THE PREPARATION OF BAZEDOXIFENE ACETATE AND INTERMEDIATES THEREOF | DIVI'S LABORATORIES LTD. (IN) | 2013-10-31 | — | — | US | disclosed |
| US-8569483-B2 | Process for the preparation of bazedoxifene acetate and intermediates thereof | Divi's Laboratories, Ltd. (IN) | 2013-10-29 | — | — | US | disclosed |
| WO-2013090836-A1 | FLUORINATED ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | ARAGON PHARMACEUTICALS, INC. (US) | 2013-06-20 | — | — | WO | disclosed |
| US-20120330008-A1 | NOVEL PROCESS FOR THE PREPARATION OF BAZEDOXIFENE ACETATE AND INTERMEDIATES THEREOF | DIVI'S LABORATORIES LIMITED (IN) | 2012-12-27 | — | — | US | disclosed |
| US-20120252769-A1 | 2-PHENYL-1-[4-(2-AMINOETHOXY)-BENZYL]-INDOLE AND ESTROGEN FORMULATIONS | WYETH LLC (US) | 2012-10-04 | — | — | US | disclosed |
| CN-102690225-A | New synthetic method of bazedoxifene | NANJING YOUJIE MEDICAL TECHNOLOGY CO LTD | 2012-09-26 | — | — | CN | disclosed |
| EP-2311805-B1 | New polymorphic form of bazedoxifene acetate | ZENTIVA KS (CZ) | 2012-05-09 | — | — | EP | disclosed |
| EP-2118058-B9 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA KS (CZ) | 2012-03-28 | — | — | EP | disclosed |
| EP-2118058-B9 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA KS (CZ) | 2012-03-28 | — | — | EP | disclosed |
| EP-2118058-B9 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA KS (CZ) | 2012-03-28 | — | — | EP | disclosed |
| EP-2118058-B9 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA KS (CZ) | 2012-03-28 | — | — | EP | disclosed |
| EP-2426105-A1 | Process for the preparation of 5-benzyloxy-2-(4-benzyloxyphenyl)-3-methyl-1h-indole | Divi's Laboratories Limited (IN) | 2012-03-07 | — | — | EP | disclosed |
| EP-2426105-A1 | Process for the preparation of 5-benzyloxy-2-(4-benzyloxyphenyl)-3-methyl-1h-indole | Divi's Laboratories Limited (IN) | 2012-03-07 | — | — | EP | disclosed |
| EP-2426105-A1 | Process for the preparation of 5-benzyloxy-2-(4-benzyloxyphenyl)-3-methyl-1h-indole | Divi's Laboratories Limited (IN) | 2012-03-07 | — | — | EP | disclosed |
| EP-2426105-A1 | Process for the preparation of 5-benzyloxy-2-(4-benzyloxyphenyl)-3-methyl-1h-indole | Divi's Laboratories Limited (IN) | 2012-03-07 | — | — | EP | disclosed |
| US-8034807-B2 | Salts of bazedoxifene | ZENTIVA K.S. (CZ) | 2011-10-11 | — | — | US | disclosed |
| US-8034807-B2 | Salts of bazedoxifene | ZENTIVA K.S. (CZ) | 2011-10-11 | — | — | US | disclosed |
| US-7968732-B1 | Process for the preparation of 5-benzyloxy-2-(4-benzyloxyphenyl)-3-methyl-1H-indole | Divi's Laboratories, Ltd. (IN) | 2011-06-28 | — | — | US | disclosed |
| US-7968732-B1 | Process for the preparation of 5-benzyloxy-2-(4-benzyloxyphenyl)-3-methyl-1H-indole | Divi's Laboratories, Ltd. (IN) | 2011-06-28 | — | — | US | disclosed |
| US-7968732-B1 | Process for the preparation of 5-benzyloxy-2-(4-benzyloxyphenyl)-3-methyl-1H-indole | Divi's Laboratories, Ltd. (IN) | 2011-06-28 | — | — | US | disclosed |
| US-7968732-B1 | Process for the preparation of 5-benzyloxy-2-(4-benzyloxyphenyl)-3-methyl-1H-indole | Divi's Laboratories, Ltd. (IN) | 2011-06-28 | — | — | US | disclosed |
| US-7968732-B1 | Process for the preparation of 5-benzyloxy-2-(4-benzyloxyphenyl)-3-methyl-1H-indole | Divi's Laboratories, Ltd. (IN) | 2011-06-28 | — | — | US | disclosed |
| EP-2118058-B1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA KS (CZ) | 2011-06-08 | — | — | EP | disclosed |
| EP-2118058-B1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA KS (CZ) | 2011-06-08 | — | — | EP | disclosed |
| EP-2118058-B1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA KS (CZ) | 2011-06-08 | — | — | EP | disclosed |
| EP-2118058-B1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA KS (CZ) | 2011-06-08 | — | — | EP | disclosed |
| EP-2311805-A1 | New polymorphic form of bazedoxifene acetate | Zentiva, K.S. (CZ) | 2011-04-20 | — | — | EP | disclosed |
| EP-2185510-B1 | NEW SALTS OF BAZEDOXIFENE | ZENTIVA KS (CZ) | 2011-04-06 | — | — | EP | disclosed |
| WO-2011022596-A2 | PREPARATION OF BAZEDOXIFENE AND ITS SALTS | DR. REDDY'S LABORATORIES LTD. (IN) | 2011-02-24 | — | — | WO | disclosed |
| US-20100240888-A1 | SALTS OF BAZEDOXIFENE | ZENTIVA K.S. (CZ) | 2010-09-23 | — | — | US | disclosed |
| US-20100240888-A1 | SALTS OF BAZEDOXIFENE | ZENTIVA K.S. (CZ) | 2010-09-23 | — | — | US | disclosed |
| EP-2185510-A2 | NEW SALTS OF BAZEDOXIFENE | Zentiva, K.S. (CZ) | 2010-05-19 | — | — | EP | disclosed |
| US-20100087661-A1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA K.S. (CZ) | 2010-04-08 | — | — | US | disclosed |
| US-20100087661-A1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA K.S. (CZ) | 2010-04-08 | — | — | US | disclosed |
| US-20100087661-A1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA K.S. (CZ) | 2010-04-08 | — | — | US | disclosed |
| US-20100087661-A1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA K.S. (CZ) | 2010-04-08 | — | — | US | disclosed |
| US-20100087661-A1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA K.S. (CZ) | 2010-04-08 | — | — | US | disclosed |
| EP-2118058-A1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | Zentiva, k.s. (CZ) | 2009-11-18 | — | — | EP | disclosed |
| EP-2118058-A1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | Zentiva, k.s. (CZ) | 2009-11-18 | — | — | EP | disclosed |
| EP-2118058-A1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | Zentiva, k.s. (CZ) | 2009-11-18 | — | — | EP | disclosed |
| US-20090176764-A1 | 2-PHENYL-1-[4-(2-AMINOETHOXY)-BENZYL]-INDOLES AS ESTROGENIC AGENTS | WYETH (US) | 2009-07-09 | — | — | US | disclosed |
| US-20090176764-A1 | 2-PHENYL-1-[4-(2-AMINOETHOXY)-BENZYL]-INDOLES AS ESTROGENIC AGENTS | WYETH (US) | 2009-07-09 | — | — | US | disclosed |
| WO-2009012734-A2 | NEW SALTS OF BAZEDOXIFENE | ZENTIVA A.S. (CZ) | 2009-01-29 | — | — | WO | disclosed |
| US-7449455-B2 | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | WYETH (US) | 2008-11-11 | — | — | US | disclosed |
| US-7449455-B2 | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | WYETH (US) | 2008-11-11 | — | — | US | disclosed |
| WO-2008098527-A1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA A.S. (CZ) | 2008-08-21 | — | — | WO | disclosed |
| WO-2008098527-A1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA A.S. (CZ) | 2008-08-21 | — | — | WO | disclosed |
| WO-2008098527-A1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA A.S. (CZ) | 2008-08-21 | — | — | WO | disclosed |
| WO-2008098527-A1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | ZENTIVA A.S. (CZ) | 2008-08-21 | — | — | WO | disclosed |
| US-20080021017-A1 | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | WYETH (US) | 2008-01-24 | — | — | US | disclosed |
| US-20080021017-A1 | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | WYETH (US) | 2008-01-24 | — | — | US | disclosed |
| CN-100339371-C | Novel aryloxy-alkyl-dialkylamines compound | AMERICAN HOME PROD (US) | 2007-09-26 | — | — | CN | disclosed |
| US-7247624-B2 | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | WYETH (US) | 2007-07-24 | — | — | US | disclosed |
| US-7247624-B2 | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | WYETH (US) | 2007-07-24 | — | — | US | disclosed |
| US-20070142361-A1 | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations | WYETH (US) | 2007-06-21 | — | — | US | disclosed |
| US-20070142361-A1 | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations | WYETH (US) | 2007-06-21 | — | — | US | disclosed |
| US-20070135396-A1 | 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations | WYETH (US) | 2007-06-14 | — | — | US | disclosed |
| US-20070135396-A1 | 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations | WYETH (US) | 2007-06-14 | — | — | US | disclosed |
| US-20070135397-A1 | 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations | WYETH (US) | 2007-06-14 | — | — | US | disclosed |
| US-20070135397-A1 | 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations | WYETH (US) | 2007-06-14 | — | — | US | disclosed |
| EP-1777214-A2 | Novel aryloxy-alkyl-dialkylamines | Wyeth (US) | 2007-04-25 | — | — | EP | disclosed |
| US-20070054895-A1 | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | WYETH (US) | 2007-03-08 | — | — | US | disclosed |
| US-20070054895-A1 | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | WYETH (US) | 2007-03-08 | — | — | US | disclosed |
| EP-1025077-B1 | NOVEL ARYLOXY-ALKYL-DIALKYLAMINES | WYETH CORP (US) | 2007-02-28 | — | — | EP | disclosed |
| US-7138392-B2 | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | MILLER CHRIS P | 2006-11-21 | — | — | US | disclosed |
| US-7132417-B2 | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | WYETH (US) | 2006-11-07 | — | — | US | disclosed |
| US-20060229296-A1 | 2-PHENYL-1-[4-(2-AMINOETHOXY)-BENZYL]-INDOLES AS ESTROGENIC AGENTS | WYETH (US) | 2006-10-12 | — | — | US | disclosed |
| US-20060211666-A1 | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations | WYETH (US) | 2006-09-21 | — | — | US | disclosed |
| US-7041663-B2 | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | WYETH (US) | 2006-05-09 | — | — | US | disclosed |
| US-20060094711-A1 | 2-PHENYL-1-[4-(2-AMINOETHOXY)-BENZYL]-INDOLES AS ESTROGENIC AGENTS | WYETH (US) | 2006-05-04 | — | — | US | disclosed |
| CN-1765891-A | Novel aryloxy-alkyl-dialkylamines compound | AMERICAN HOME PROD (US) | 2006-05-03 | — | — | CN | disclosed |
| EP-1212335-B1 | GLUCOPYRANOSIDES CONJUGATES OF 2-(4-HYDROXY-PHENYL)-1- 4-(2-AMIN-1-YL-ETHOXY)-BENZYL]-1H-INDOL-5-OLS | WYETH CORP (US) | 2006-01-18 | — | — | EP | disclosed |
| CN-1231458-C | Novel aryloxy-alkyl-dialkylamines | WYETH CORP (US) | 2005-12-14 | — | — | CN | disclosed |
| CN-1230163-C | 2-phenyl-1- [4- (2-aminoethoxy) -benzyl ] -indole in combination with an estrogen | AMERICAN HOME PROD (US) | 2005-12-07 | — | — | CN | disclosed |
| US-6951852-B2 | 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indoles as estrogenic agents | WYETH (US) | 2005-10-04 | — | — | US | disclosed |
| US-20050215616-A1 | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | WYETH (US) | 2005-09-29 | — | — | US | disclosed |
| US-6924281-B2 | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | WYETH (US) | 2005-08-02 | — | — | US | disclosed |
| CN-1196708-C | Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl)-1h-indol-5-ols | AMERICAN HOME PROD (US) | 2005-04-13 | — | — | CN | disclosed |
| US-20050026905-A1 | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | WYETH (US) | 2005-02-03 | — | — | US | disclosed |
| US-6835729-B2 | 2-phenyl-1-[4(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | WYETH | 2004-12-28 | — | — | US | disclosed |
| US-20040229932-A1 | 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indoles as estrogenic agents | WYETH | 2004-11-18 | — | — | US | disclosed |
| US-6787538-B2 | HORMONE REPLACEMENT THERAPY; AGONISTS, ANTAGONISTS; ANTIESTROGENS WITH LITTLE TO NO INTRINSIC ESTROGENICITY | WYETH | 2004-09-07 | — | — | US | disclosed |
| US-20040110824-A1 | 2-Phenyl-1-[4(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | WYETH | 2004-06-10 | — | — | US | disclosed |
| US-20040110823-A1 | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | WYETH | 2004-06-10 | — | — | US | disclosed |
| US-20030203883-A1 | For alleviating symptoms of post-menopausal syndrome; hormone replacement therapy; for treating endometriosis | WYETH | 2003-10-30 | — | — | US | disclosed |
| EP-1076558-B1 | 2-PHENYL-1-[-(2-AMINOETHOXY)-BENZYL -INDOLE IN COMBINATION WITH ESTROGENS | WYETH CORP (US) | 2003-07-16 | — | — | EP | disclosed |
| US-20030130274-A1 | 2-Phenyl-1-[4-(2-aminoethoxy)benzyl-indoles as estrogenic agents | WYETH | 2003-07-10 | — | — | US | disclosed |
| US-6583170-B1 | Hormone replacement therapy to maintain the bone sparing effect while minimizing the proliferative effects in the uterus and breast; estrogen agonists/antagonists | WYETH | 2003-06-24 | — | — | US | disclosed |
| CN-1103756-C | Estrogenic agents | WYETH HOME PRODUCTS CORP (US) | 2003-03-26 | — | — | CN | disclosed |
| US-6537971-B2 | Useful as tissue selective estrogenic agents, for therapy and prophylaxis of cardiovascular disorders, for increasing cognition or treating or inhibiting dementias or Alzheimer's Disease | WYETH | 2003-03-25 | — | — | US | disclosed |
| CN-1382151-A | Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl)-1h-indol-5-ols | AMERICAN HOME PROD (US) | 2002-11-27 | — | — | CN | disclosed |
| US-6479535-B1 | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations | WYETH | 2002-11-12 | — | — | US | disclosed |
| US-20020142971-A1 | Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols | AMERICAN HOME PRODUCTS CORPORATION | 2002-10-03 | — | — | US | disclosed |
| EP-0802184-B1 | N-Benzyl-2-phenylindoles as estrogenic agents | WYETH CORP (US) | 2002-06-19 | — | — | EP | disclosed |
| US-6380185-B1 | FOR PREVENTION OF OSTEOPOROSIS, BONE LOSS | AMERICAN HOME PRODUCTS CORPORATION | 2002-04-30 | — | — | US | disclosed |
| US-6380166-B1 | USEFUL AS TISSUE ELECTIVE ESTROGENIC AGENTS, USED IN HORMONE REPLACEMENT THERAPY FOR BONE LOSS PREVENTION IN POST-MENOPAUSAL WOMEN | AMERICAN HOME PRODUCTS CORPORATION | 2002-04-30 | — | — | US | disclosed |
| CN-1342144-A | N-substituted benzoyl indoles as estrogenic agents | AMERICAN HOME PROD (US) | 2002-03-27 | — | — | CN | disclosed |
| CN-1326347-A | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens | AMERICAN HOME PROD (US) | 2001-12-12 | — | — | CN | disclosed |
| EP-1159268-A1 | N-SUBSTITUTED BENzOYL INDOLES AS ESTROGENIC AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 2001-12-05 | — | — | EP | disclosed |
| US-6326367-B1 | THERAPY FOR OVARIAN CANCER | AMERICAN HOME PRODUCTS CORPORATION | 2001-12-04 | — | — | US | disclosed |
| EP-0802183-B1 | Estrogenic agents | AMERICAN HOME PROD (US) | 2001-10-10 | — | — | EP | disclosed |
| US-6291451-B1 | USEFUL IN THE TREATMENT OR INHIBITION OF BREAST CANCER. | AMERICAN HOME PRODUCTS CORPORATION | 2001-09-18 | — | — | US | disclosed |
| US-20010021719-A1 | 2-phenyl-1- [4- (2-aminoethoxy) - benzyl] - indoles as estrogenic agents | WYETH | 2001-09-13 | — | — | US | disclosed |
| CN-1309637-A | Compositions comprising 2-phenyl-indole compounds and estrogen formutations | AMERICAN HOME PROD (US) | 2001-08-22 | — | — | CN | disclosed |
| US-6268504-B1 | USED IN THE PRODUCTION OF PHARMACEUTICAL PRODUCTS | AMERICAN HOME PRODUCTS CORPORATION | 2001-07-31 | — | — | US | disclosed |
| US-6242605-B1 | Aryloxy-alkyl-dialkylamines | AMERICAN HOME PRODUCTS CORPORATION | 2001-06-05 | — | — | US | disclosed |
| US-6232307-B1 | 2-PHENYL-1-(4-(2-AMINOETHOXY)-BENZYL)-INDOLE COMPOUNDS USEFUL AS ESTROGENIC AGENTS | AMERICAN HOME PRODUCTS CORPORATION | 2001-05-15 | — | — | US | disclosed |
| US-6225308-B1 | 2-PHENYL-1-(4-(2-AMINOETHOXY)-BENZYL)-INDOLE COMPOUNDS WHICH ARE USEFUL AS ESTROGENIC AGENTS | AMERICAN HOME PRODUCTS CORPORATION | 2001-05-01 | — | — | US | disclosed |
| EP-1080073-A1 | COMPOSITIONS COMPRISING 2-PHENYL-INDOLE COMPOUNDS AND ESTROGEN FORMULATIONS | AMERICAN HOME PRODUCTS CORPORATION (US) | 2001-03-07 | — | — | EP | disclosed |
| EP-1076558-A1 | 2-PHENYL-1-[-(2-AMINOETHOXY)-BENZYL -INDOLE IN COMBINATION WITH ESTROGENS | AMERICAN HOME PRODUCTS CORPORATION (US) | 2001-02-21 | — | — | EP | disclosed |
| CN-1281429-A | Novel aryloxy-alkyl-dialkylamines | AMERICAN HOME PROD (US) | 2001-01-24 | — | — | CN | disclosed |
| US-6127404-A | 2-PHENYL-1-(4-(2-AMINOETHOXY)-BENZYL)INDOLE COMPOUNDS USEFUL AS ESTROGEN AGONISTS/ANTAGONISTS; OSTEOPOROSIS; ANTICHOLESTEROL AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 2000-10-03 | — | — | US | disclosed |
| WO-2000051983-A1 | N-SUBSTITUTED BENzOYL INDOLES AS ESTROGENIC AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 2000-09-08 | — | — | WO | disclosed |
| EP-1025077-A1 | NOVEL ARYLOXY-ALKYL-DIALKYLAMINES | AMERICAN HOME PRODUCTS CORPORATION (US) | 2000-08-09 | — | — | EP | disclosed |
| US-6005102-A | NOVEL INTERMEDIATES WHICH MAY BE USED IN THE PRODUCTION OF PHARMACEUTICAL COMPOUNDS FOR ANTI-ESTROGENIC AND MATRIX METALLOPROTEINASES-INHIBITING UTILITIES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1999-12-21 | — | — | US | disclosed |
| US-5998402-A | OSTEOPOROSIS; CARDIOVASCULAR DISORDERS; ANTICANCER AGENTS;POSTMEMOPAUSE THERAPY | AMERICAN HOME PRODUCTS CORPORATION (US) | 1999-12-07 | — | — | US | disclosed |
| WO-1999059581-A1 | 2-PHENYL-1-[4-(2-AMINOETHOXY)-BENZYL]-INDOLE IN COMBINATION WITH ESTROGENS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1999-11-25 | — | — | WO | disclosed |
| WO-1999059969-A1 | COMPOSITIONS COMPRISING 2-PHENYL-INDOLE COMPOUNDS AND ESTROGEN FORMULATIONS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1999-11-25 | — | — | WO | disclosed |
| US-5985910-A | ESTROGEN AGONISTS/ANTAGONISTS USEFUL FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ESTROGEN DEFICIENCY | AMERICAN HOME PRODUCTS CORPORATION (US) | 1999-11-16 | — | — | US | disclosed |
| WO-1999019293-A1 | NOVEL ARYLOXY-ALKYL-DIALKYLAMINES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1999-04-22 | — | — | WO | disclosed |
| US-5880137-A | PREVENTING ESTROGEN DEFICIENCY DISEASES OR SYNDROMES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1999-03-09 | — | — | US | disclosed |
| US-5780497-A | ESTROGEN AGONISTS; OSTEOPOROSIS TREATMENT, ANTICANCER AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1998-07-14 | — | — | US | disclosed |
| CN-1170719-A | Estrogenic agents | AMERICAN HOME PROD (US) | 1998-01-21 | — | — | CN | disclosed |
| CN-1168373-A | Estrogenic agents | AMERICAN HOME PROD (US) | 1997-12-24 | — | — | CN | disclosed |
| EP-0802183-A1 | Estrogenic agents | AMERICAN HOME PRODUCTS CORPORATION (US) | 1997-10-22 | — | — | EP | disclosed |
| EP-0802183-A1 | Estrogenic agents | AMERICAN HOME PRODUCTS CORPORATION (US) | 1997-10-22 | — | — | EP | disclosed |
| EP-0802184-A1 | N-Benzyl-2-phenylindoles as estrogenic agents | AMERICAN HOME PRODUCTS CORPORATION (US) | 1997-10-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (34 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040229932-A1 | 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indoles as estrogenic agents | ESR2, ESR1, GPER1 | TRPM8 3581/4885MAOA 311/4885MAOB 425/4885 |
| US-20010021719-A1 | 2-phenyl-1- [4- (2-aminoethoxy) - benzyl] - indoles as estrogenic agents | ESR1, ESR2, GPER1 | TRPM8 3089/4885MAOA 262/4885MAOB 454/4885 |
| US-20140329784-A1 | 2-PHENYL-1-[4-(2-AMINOETHOXY)-BENZYL]-INDOLE AND ESTROGEN FORMULATIONS | ESR2, ESR1, CYP19A1 | TRPM8 3117/4885MAOA 168/4885MAOB 166/4885 |
| US-20120330008-A1 | NOVEL PROCESS FOR THE PREPARATION OF BAZEDOXIFENE ACETATE AND INTERMEDIATES THEREOF | CYP19A1, HSD17B11, SULT1E1 | TRPM8 3479/4885MAOA 289/4885MAOB 307/4885 |
| US-20120252769-A1 | 2-PHENYL-1-[4-(2-AMINOETHOXY)-BENZYL]-INDOLE AND ESTROGEN FORMULATIONS | ESR2, ESR1, CYP19A1 | TRPM8 3117/4885MAOA 168/4885MAOB 166/4885 |
| US-20100240888-A1 | SALTS OF BAZEDOXIFENE | CYP19A1, SHBG, NR5A1 | TRPM8 4395/4885MAOA 975/4885MAOB 1818/4885 |
| US-20210040081-A1 | INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | ESR1, GPER1, ESR2 | TRPM8 319/4885MAOA 23/4885MAOB 42/4885 |
| US-10865202-B2 | Indole derivatives as estrogen receptor degraders | ESR1, GPER1, ESR2 | TRPM8 319/4885MAOA 23/4885MAOB 42/4885 |
| US-11667621-B2 | Antiestrogen compounds | ESR1, ESR2, ESRRG | TRPM8 3294/4885MAOA 3828/4885MAOB 4228/4885 |
| US-20070135397-A1 | 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations | ESR2, ESR1, CYP19A1 | TRPM8 3117/4885MAOA 168/4885MAOB 166/4885 |
| US-20100087661-A1 | METHOD FOR THE PREPARATION OF 5-BENZYLOXY-2-(4-BENZYLOXPHENYL)-3-METHYL-1H-INDOLE | CYP19A1, CYP17A1, SHBG | TRPM8 4576/4885MAOA 110/4885MAOB 85/4885 |
| US-20230158152-A1 | PROTEOLYSIS REGULATOR AND METHOD FOR USING SAME | PSMA6, PSMC1, PSMA1 | TRPM8 4043/4885MAOA 3559/4885MAOB 3855/4885 |
| US-20180072711-A1 | INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | ESR1, GPER1, ESR2 | TRPM8 319/4885MAOA 23/4885MAOB 42/4885 |
| US-20030130274-A1 | 2-Phenyl-1-[4-(2-aminoethoxy)benzyl-indoles as estrogenic agents | ESR2, ESR1, GPER1 | TRPM8 3397/4885MAOA 319/4885MAOB 415/4885 |
| US-20040110824-A1 | 2-Phenyl-1-[4(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | ESR2, ESR1, GPER1 | TRPM8 3446/4885MAOA 337/4885MAOB 427/4885 |
| US-20020142971-A1 | Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols | SHBG, GPER1, SULT1E1 | TRPM8 4257/4885MAOA 3140/4885MAOB 3211/4885 |
| US-11584743-B2 | Indole derivatives as estrogen receptor degraders | ESR1, GPER1, ESR2 | TRPM8 319/4885MAOA 23/4885MAOB 42/4885 |
| US-20060229296-A1 | 2-PHENYL-1-[4-(2-AMINOETHOXY)-BENZYL]-INDOLES AS ESTROGENIC AGENTS | ESR2, ESR1, SHBG | TRPM8 4453/4885MAOA 458/4885MAOB 454/4885 |
| US-20060211666-A1 | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations | ESR2, ESR1, CYP19A1 | TRPM8 3117/4885MAOA 168/4885MAOB 166/4885 |
| US-20050215616-A1 | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | CYP19A1, ESR2, ESR1 | TRPM8 2827/4885MAOA 173/4885MAOB 226/4885 |
| US-20070135396-A1 | 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations | ESR2, ESR1, CYP19A1 | TRPM8 3117/4885MAOA 168/4885MAOB 166/4885 |
| US-20150005286-A1 | FLUORINATED ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | GPER1, ESR2, ESRRG | TRPM8 555/4885MAOA 1417/4885MAOB 1383/4885 |
| US-20030203883-A1 | For alleviating symptoms of post-menopausal syndrome; hormone replacement therapy; for treating endometriosis | ESR2, GPER1, ESR1 | TRPM8 2257/4885MAOA 312/4885MAOB 325/4885 |
| US-20130289296-A1 | NOVEL PROCESS FOR THE PREPARATION OF BAZEDOXIFENE ACETATE AND INTERMEDIATES THEREOF | CYP19A1, HSD17B11, SULT1E1 | TRPM8 3479/4885MAOA 289/4885MAOB 307/4885 |
| US-20040110823-A1 | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | ESR2, ESR1, GPER1 | TRPM8 3581/4885MAOA 311/4885MAOB 425/4885 |
| US-20210130320-A1 | ANTIESTROGEN COMPOUNDS | ESR1, ESR2, ESRRG | TRPM8 3294/4885MAOA 3828/4885MAOB 4228/4885 |
| US-20050026905-A1 | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | ESR2, ESR1, GPER1 | TRPM8 3356/4885MAOA 274/4885MAOB 323/4885 |
| US-20070142361-A1 | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations | ESR1, ESR2, CYP19A1 | TRPM8 2935/4885MAOA 176/4885MAOB 179/4885 |
| US-20090176764-A1 | 2-PHENYL-1-[4-(2-AMINOETHOXY)-BENZYL]-INDOLES AS ESTROGENIC AGENTS | BRCA1, ESR2, PKD2 | TRPM8 3756/4885MAOA 1358/4885MAOB 1015/4885 |
| US-20080021017-A1 | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | BRCA1, PKD2, CYP19A1 | TRPM8 2993/4885MAOA 1037/4885MAOB 667/4885 |
| US-10844047-B2 | Process for the preparation of bazedoxifene | CYP19A1, CYP3A5, CYP4A11 | TRPM8 3544/4885MAOA 140/4885MAOB 174/4885 |
| US-20190233408-A1 | INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS | ESR1, GPER1, ESR2 | TRPM8 319/4885MAOA 23/4885MAOB 42/4885 |
| US-20060094711-A1 | 2-PHENYL-1-[4-(2-AMINOETHOXY)-BENZYL]-INDOLES AS ESTROGENIC AGENTS | ESR2, GPER1, CYP19A1 | TRPM8 3296/4885MAOA 325/4885MAOB 328/4885 |
| US-20070054895-A1 | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents | ESR2, GPER1, ESR1 | TRPM8 4278/4885MAOA 310/4885MAOB 400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.